Yüklüyor......
Drug-Drug Interaction Study of Ketoconazole and Ritonavir-Boosted Saquinavir
Saquinavir, a potent human immunodeficiency virus protease inhibitor, is extensively metabolized by CYP3A4. Saquinavir is coadministered with ritonavir, a strong CYP3A4 inhibitor, to boost its exposure. Ketoconazole is a potent CYP3A inhibitor. The objectives of this study were to investigate the ef...
Kaydedildi:
| Asıl Yazarlar: | , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society for Microbiology (ASM)
2009
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2630604/ https://ncbi.nlm.nih.gov/pubmed/19015329 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00769-08 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|